title: MR spectroscopy of bilateral thalamic gliomas.
abstract: This study reports the MR spectroscopic patterns of two patients with bithalamic glioma. In one patient, phosphorus (31P) MR spectroscopy was performed. In both patients, the proton MR spectroscopic scans showed an increased creatine-phosphocreatine peak in the tumor. In the patient who underwent 31P-MR spectroscopy, an increased phosphocreatine peak was also observed. This group of thalamic tumors may be distinguished from other gliomas clinically, radiologically, and metabolically.
authors.affiliation: Unité IRM, University Joseph Fourier, and Centre Hospitalier Universitaire de Grenoble, France.
authors.forename: F
authors.initials: F
authors.lastname: Estève
authors.forename: S
authors.initials: S
authors.lastname: Grand
authors.forename: C
authors.initials: C
authors.lastname: Rubin
authors.forename: D
authors.initials: D
authors.lastname: Hoffmann
authors.forename: B
authors.initials: B
authors.lastname: Pasquier
authors.forename: D
authors.initials: D
authors.lastname: Graveron-Demilly
authors.forename: R
authors.initials: R
authors.lastname: Mahdjoub
authors.forename: J F
authors.initials: JF
authors.lastname: Le Bas
mesh_terms: D000328:Adult; D001923:Brain Chemistry; D001932:Brain Neoplasms / Q000175:diagnosis* / Q000473:pathology; D003401:Creatine / Q000032:analysis; D005910:Glioma / Q000175:diagnosis* / Q000473:pathology; D006801:Humans; D008279:Magnetic Resonance Imaging; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D010725:Phosphocreatine / Q000032:analysis; D013786:Thalamic Diseases / Q000175:diagnosis* / Q000473:pathology; D013788:Thalamus / Q000473:pathology
chemical_list: D010725:Phosphocreatine; D003401:Creatine